Publisher
Springer Science and Business Media LLC
Reference238 articles.
1. McCutcheon RA, Marques TR, Howes OD. Schizophrenia—an overview. JAMA Psychiat. 2020;77(2):201–10.
2. Searles HF. Schizophrenia and the inevitability of death. Psychiatr Q. 1961;35(4):631–65.
3. Javitt DC. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview. Am J Manag Care. 2014;20(8 Suppl):S160–5.
4. James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.
5. Sokan A. Daily use of the medication adherence mobile phone application, Medisafe, to improve adherence over a 10-week period among African American adults, ages 25-60 years, diagnosed with schizophrenia. University of Massachusetts Global; 2023. No: 30425489.